sorafenib has been researched along with Esophageal and Gastric Varices in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Allaire, M; Blaise, L; Campion, B; Cluzel, P; Evain, M; Ganne-Carrié, N; Giudicelli, H; Larrey, E; Rudler, M; Sultanik, P; Thabut, D; Wagner, M | 1 |
Chung, CY; Wu, SS; Yen, HH | 1 |
Aubourg, A; Bacq, Y; Lucas, E; Perarnau, JM | 1 |
3 other study(ies) available for sorafenib and Esophageal and Gastric Varices
Article | Year |
---|---|
A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCC.
Topics: Bevacizumab; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Prospective Studies; Retrospective Studies; Sorafenib | 2022 |
Oesophageal variceal bleeding in hepatocellular carcinoma with portal vein thrombosis: improved outcome in response to molecular target therapy.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Pyridines; Sorafenib; Venous Thrombosis | 2008 |
Coil extrusion from a gastric varice during sorafenib treatment for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Neoplasms; Middle Aged; Niacinamide; Phenylurea Compounds; Portasystemic Shunt, Transjugular Intrahepatic; Prosthesis Failure; Pyridines; Sorafenib | 2011 |